We studied 60 patients during stable isoflurane anaesthesia (0.4 MAC) after premedication with temazepam. Patients were allocated randomly to one of three dose regimens of remifentanil: 1 g (high dose). The auditory (AER) and median nerve somatosensory (SER) responses were elicited throughout, and recorded before and after tracheal intubation, and surgical incision, together with systolic and diastolic arterial pressure and heart rate. Venous blood concentrations of remifentanil were measured at the above times. After administration of remifentanil, Pa and Nb amplitudes of the AER increased at the low dose, remained constant at the medium dose and decreased at the high dose. This dose-related effect was linear and significant (P : 0.012, P : 0.05).
Opioids supplement volatile anaesthetics [1, 2] and attenuate the stress response. In high doses they allow anaesthetics doses so low that cardiovascular effects are negligible. Respiratory depressant effects persist into the postoperative period, limiting the technique to major surgery where postoperative ventilation of the lungs is appropriate. The technique could be extended to routine surgery if a very shortacting drug were available. Remifentanil (GI 87084B), a new synthetic phenyl-piperidine opioid has a very rapid onset and a short duration of action because it is metabolized in both blood and tissues by ester hydrolysis. Its pharmacokinetic profile in volunteers and patients undergoing elective inpatient surgery has been described recently [3] [4] [5] [6] . Titration of an infusion of remifentanil to produce a desired effect should be possible, making it attractive for use in anaesthesia.
We believe that evoked responses can separate the analgesic and hypnotic components of an anaesthetic. Changes in the early cortical waves of the auditory evoked response (AER) have been shown to be related to the degree of hypnosis with general anaesthetics [7, 8] , and changes in the somatosensory evoked response (SER) waves that originate in the region of the thalamus [9, 10] have been shown to reflect the action of analgesic drugs during general anaesthesia [7, 11, 12] .
We have examined the effects of three doses of remifentanil on the AER and SER recorded simultaneously during isoflurane anaesthesia. A clinically relevant nociceptive input was provided by tracheal intubation and surgical incision. This enables both testing of the direct effect of the drug during anaesthesia and its possible attenuation of arousal by stimuli.
Patients and methods
After obtaining approval from the local Ethics Committee and informed consent, we studied 60 patients, ASA I or II, undergoing elective surgery. We examined the effect of three regimens of remifentanil, administered in a random, doubleblind manner during isoflurane anaesthesia. The doses were: a bolus of remifentanil 1 g kg 91 administered over 1 min followed immediately by an infusion of 0. , and a laryngeal mask airway was inserted when consciousness had been lost. Vecuronium 0.1 mg kg 91 was given, and paralysis was maintained with an infusion of vecuronium adjusted to allow a single response to the train-of-four stimulus. Patients' lungs were ventilated to achieve an end-tidal carbon dioxide concentration of 4.5-5 %, and anaesthesia was maintained with 0.4 % isoflurane (end-expiratory) in oxygen (measured using a calibrated Datex Ultima). When the end-tidal concentration of isoflurane was stable, typically 10-15 min after induction, glycopyrronium 0.6 mg was given followed 3 min later by remifentanil according to the study design. Ephedrine 10 mg was used when a reduction in arterial pressure was considered to require intervention. Nine minutes after the remifentanil bolus, the laryngeal mask airway was removed and the patient's trachea intubated. Surgical incision occurred at least 10 min after tracheal intubation. The study ended 10 min after incision, the remifentanil infusion was discontinued and nitrous oxide was introduced into the anaesthetic gas mixture.
EVOKED POTENTIALS
Recordings of the AER were started before induction of anaesthesia in all patients. The SER was recorded when consciousness had been lost. Responses were recorded continuously throughout the study. The auditory stimulus was a rarefaction click delivered to both ears simultaneously via close-fitting earpieces. It was presented at 75 dB above the average hearing threshold at a repetition rate of 6 s
91
. The somatosensory stimulus of the median nerve at the wrist was a 150-s electrical pulse produced by a modified Duostim nerve stimulator fitted with an optically isolated trigger from the evoked responses apparatus. It was presented at a rate of 2.2 s
. The intensity was adjusted to just above the motor threshold before vecuronium was given.
The EEG was recorded for the AER using adhesive silver-silver chloride electrodes on the forehead and left mastoid, and for the SER silversilver chloride cup electrodes attached with collodion glue at Fz and C3Ј (20 mm back from C3) using the standard EEG 10-20 system. The EEG signal was analogue filtered on input with bandwidths of 25-500 Hz for the AER and 10-500 Hz for the SER. The evoked responses were displayed on two interlinked portable PCs using purpose-designed software, and the signals stored on the hard disks of these computers. After each study, the stored information was transferred onto optical disks and analysed off-line. During analysis additional digital filtering was used; a high pass filter of 20 Hz and three-point smoothing for the AER and a high pass filter of 20 Hz for the SER.
The evoked responses were averaged over a period of 2.8 min at steady state before administration of remifentanil and before and after intubation and surgical incision. From the AER, the latency and amplitude of the early cortical waves Pa and Nb were analysed. Latency is measured in milliseconds from time zero (the click). Amplitude is measured in V as the vertical distance from a peak to a line joining two adjacent troughs, or vice versa. An index of the AER generated automatically from the mean second differential of the waveform at 30-60 ms was also recorded (the second differential gives a value which increases both with amplitude and with the number of peaks occurring in the window). The SER was analysed with respect to latency of the waves P15, N20, P25, N35 and P45, and the amplitude of P15-N20, N20-P25, P25-N35 and N35-P45. The amplitudes were measured as the vertical distance (V) between successive waves.
Arterial pressure and heart rate were recorded every 3 min using a Dinamap, and throughout the procedure an ECG and pulse oximeter were attached to the patient.
REMIFENTANIL BLOOD CONCENTRATIONS
Venous blood samples were obtained in lithium heparin tubes from the contralateral arm for analysis of concentrations of remifentanil immediately before, and 3 min after intubation and correspondingly before and after surgical incision. Some of this sample (5 ml) was mixed with 20 l of 50 % citric acid and vortexed for 10 s. Aliquots of 2.5 ml 
were then stored at -20 ЊC until analysis. Remifentanil analysis was carried out by Glaxo Inc. using the method of Selinger, Lanzo and Sekut [13] . The assay had a lower limit of resolution of 0.1 ng ml 91 and a coefficient of variation of : 11.5 %.
STATISTICAL ANALYSIS
Measurements of the following variables were made at the times shown in table 1. AER, SER and haemodynamic data were normalized by log10 transformation and analysis of variance was performed. Between-subject comparisons were made for the effects of dose, and within-subject comparisons for the effects of remifentanil infusion, intubation and incision. Regressions of the above variables and log10 transformed remifentanil blood concentrations were also carried out. All calculations were performed using Genstat 5 release 3.2 (IBM PC 3086/DOS).
Results
The relationship between blood concentrations and infusion rates is illustrated in figure 1 . Concentrations increased slightly with time in all groups.
AUDITORY EVOKED RESPONSE
The effect of remifentanil on the AER is illustrated in figure 2 by group changes in Pa amplitude from baseline 1 to after incision. The three groups (low-, medium-and high-dose) showed similar values for baseline 1 and baseline 2 ( fig. 2, table 2 ). There was a significant increase in all three groups between baseline 1 and 2 (P : 0.024). Comparing baseline 2 with the next period (before intubation), when the infusion of remifentanil was in progress, Pa amplitude increased at the low dose of remifentanil, remained constant at the medium dose and decreased at the high dose. This dose-related effect was linear and statistically significant (P : 0.012). Similar changes were seen in the AER index (P : 0.001) and Nb amplitude (P : 0.05). The differences in Pa amplitude between the three groups during administration of remifentanil were maintained throughout the study. There were no statistically significant differences caused by intubation or incision for any of the AER variables. The AER index and Nb amplitude (table 2) showed similar changes to Pa amplitude, which was not unexpected as they are related variables. The changes in these variables from baseline 1 to baseline 2 showed similar trends as Pa amplitude, but these were not significant. The changes with infusion rate were borne out when the AER data were plotted against blood concentrations of remifentanil. For example, there were statistically significant decreases in Pa amplitude ( fig. 3) when individual values before and after intubation and before and after incision were plotted against blood concentration (P : 0.002, P : 0.001, P : 0.001 and P : 0.001, respectively).
SOMATOSENSORY EVOKED RESPONSE
The earlier wave P15-N20 and N20-P25 amplitudes (table 3) decreased with administration of remifentanil (baseline 2 to before intubation) at all dose B1) ) and immediately before administration of remifentanil (baseline 2 (B2)), before (Pre-int) and after (Postint) tracheal intubation and before (Pre-inc) and after (Post-inc) incision at the low-(I), medium-(᭝) and high-(G) dose regimens.
concentrations. This was significant for P15-N20 (P : 0.001) but not for N20-P25. In contrast, the later wave (P25-N35 and N35-P45) amplitudes increased significantly at all dose concentrations of remifentanil (P : 0.001 and P : 0.001, respectively). None of these changes was dose related.
There were significant linear dose-related changes in P15-N20 and N35-P45 amplitudes after intubation (P : 0.001, P : 0.027). The amplitudes increased in the low-dose group, were virtually changed in the medium-dose group and decreased in the high-dose group. This is in contrast with the AER variables where no such linear dose-related trends with intubation were observed. Figure 4 shows the differences before and after intubation for P15-N20 amplitude of the SER and Pa amplitude of the AER.
The SER observations were borne out in the 5 ). There were no significant relationships between any of the SER variables, before and after intubation and before and after incision, and remifentanil blood concentration, but there were significant relationships between the differences in P15 and P25 latencies before and after intubation which increased (P : 0.001 and P : 0.04), and P15-N20 ( fig. 5 ) and N35-P45 amplitudes which decreased (P : 0.001 and P : 0.04), with increasing blood concentrations of remifentanil.
As with the AER variables there were no significant effects of incision on any of the somatosensory evoked response amplitudes.
HAEMODYNAMIC DATA
The haemodynamic effects of remifentanil are shown in table 4. After bolus administration of remifentanil, all three variables (systolic and diastolic arterial pressures and heart rate) decreased significantly in a linearly dose-related manner (P : 0.033, P : 0.001, P : 0.001, respectively).
Two patients in the high-dose group were given ephedrine to supplement fluids in maintaining arterial pressure within the clinical range 15 and 6 min after the bolus of remifentanil. The first of these and another different patient were given ephedrine after incision for the same reason. At the three dose concentrations of remifentanil, systolic and diastolic arterial pressures and heart rate increased significantly after intubation (P : 0.001, P : 0.001, P : 0.01, respectively), and systolic and diastolic arterial pressures increased significantly after incision (P : 0.027, P : 0.039). These changes occurred at all doses and were also reflected in the relationship with blood concentrations. Diastolic and systolic arterial pressures after intubation were inversely related to remifentanil blood concentrations (P : 0.002 and P : 0.001, respectively). Heart rate before intubation was significantly inversely related to blood concentrations of remifentanil (P : 0.001).
Discussion
As venous blood concentrations of remifentanil increased steadily with time at all dose concentrations ( fig. 1) , steady state was not reached during the study, and concentrations within a dose group were variable at each measurement time. The higher variability of pre-intubation concentrations and their lower mean values compared with subsequent measurements demonstrate that the loading bolus doses were not large enough. In a pilot study, greater bolus doses had produced unacceptable hypotension. We have presented the results in relation to dose, and measured blood concentrations, because it is not yet clear which has the closest relationship to the pharmacodynamic response. In this study there was no real difference in the results between dose and blood concentration. Although none of the doses used was able to completely suppress the cardiovascular effects of stimuli, the changes in cardiovascular variables were small and not clinically significant (table 4) .
Studies which have compared remifentanil with alfentanil have reported greater haemodynamic stability with remifentanil, irrespective of the dose rate [6, 14] . In both of these studies the haemodynamic changes were also small. In one [6] , the remifentanil infusion rate was increased before strong stimulation, which demonstrates that the short half-life of remifentanil [15] may allow greater control of haemodynamic state. The extent to which these doses are effective remains to be seen when the drug is studied in patients with greater cardiovascular instability.
As studies by other workers [16] [17] [18] have demonstrated little or no effect of opioids on the AER, we were surprised to see a dose-dependent effect on the AER variables. This would not have been detected with only one dose. In patients receiving the low dose, AER amplitudes increased. It is likely that this was the continuation of a trend which was occurring throughout the baseline period (see fig. 2 ) reaching a maximum at the pre-intubation measurement. The later SER wave amplitudes P25-N35 and N35-P45 (table 3) also increased after bolus administration of remifentanil, unlike the earlier waves P15-N20 and N20-P25 which decreased. One explanation for these observations is a decrease in depth of anaesthesia caused by factors such as reducing blood concentration of propofol, discomfort of the laryngeal mask and arterial pressure cuff. Until the preintubation measurement, the changes in Pa amplitude in the three patients groups were not significantly different from each other. From the post-intubation measurement onwards, the low dose of remifentanil arrested the trend, and the medium and high doses reversed it, resulting in the linear dose-dependent relationship.
The SER waves did not show a dose-dependent relationship. Previously, we observed later cortical SER waves behaving differently from the earlier pontine thalamic waves and in a similar manner to the cortical AER when we compared the effects of isoflurane and nitrous oxide [7] . We found that nitrous oxide decreased the amplitudes of the earlier complexes P15-N20 and N20-P25 more than isoflurane, suggesting that these subcortical waves may reflect analgesia. In contrast, isoflurane decreased the amplitudes of the later waves P25-N35 and N35-P45. The findings of this study support the suggestion that cortical waves reflect the hypnotic component of anaesthesia. Freye, Buhl and Ciaramelli [12] showed a dose-related decrease in the amplitude of N20 in response to alfentanil, and also that this response was related to the action of mu opioids, whereas opioids with a strong kappa activity affected the cortical SER waves.
This study was designed to demonstrate the effect of remifentanil on the changes in the evoked responses to strong stimuli which have been reported previously by us and others [8, 19, 20] . On this occasion both tracheal intubation and incision were included. There was no change in the AER variables in response to either stimulus ( fig. 2 ). It would have been more impressive to show a graded attenuation of the effect of stimulation on the AER amplitudes such as was seen in the changes in SER amplitudes ( fig. 4, table 3 ). Inclusion of a "no remifentanil" control or lower dose ranges of remifentanil had been contemplated but rejected because of the risk of awareness in patients undergoing tracheal intubation and incision receiving only 0.4 % isoflurane after temazepam and propofol, and with no analgesic. In early experiences with a new drug, choice of dose range is a notoriously difficult decision and we were not prepared to give less than the low dose described here. In the light of our findings, future studies using the same background anaesthesia and lower remifentanil doses could perhaps be considered.
The SER showed a response to intubation but the AER did not. Sebel and colleagues [21] have previously reported a similar SER response to intubation in patients during thiopentone and nitrous oxide anaesthesia, and after administration of fentanyl a response to surgical incision. The mechanism of the response to one stimulus (the median nerve SER) being enhanced by another unrelated stimulus (surgery or intubation) requires explanation. One possibility is a local increase in available neurotransmitters in response to a large nociceptive insult. Another possibility is an effect regulated through the mechanism of CNS arousal. This effect is blocked by increasing concentrations of opioid. While the lowest dose of opioid was insufficient to inhibit the SER, no responses were seen in the AER.
The dose-dependent depressant effects of remifentanil on the early cortical AER in the unstimulated patient have yet to be explained. There are three possibilities: first that remifentanil has an interaction with isoflurane-a combined effect on the cortex; second, that deafferentation, that is a general dampening down of incoming stimulation, produces cortical depression; and third, that mu opioids may have a direct depressive effect on the cortex.
